After the world's No. 1 drug maker announced it would exit Exubera, its partner, Nektar Therapeutics, said it only learned of Pfizer's decision from Pfizer's press release. If Pfizer cannot properly market drugs or develop drugs, the outlook for its share price looks muted. There are better plays elsewhere.

Always stick with the stars. Dog stocks like Pfizer could be stuck in the mud for a while. You want to make money now.

The only reason to buy this stock is the dividend yield.